http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1185970-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 |
| filingDate | 1982-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1985-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b442a184be09d3702b1465e218fe0e34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_409f1914fd481091f05399e8c8878ed4 |
| publicationDate | 1985-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1185970-A |
| titleOfInvention | Benzo-fused heterocyclic anti-ulcer agents |
| abstract | ABSTRACT OF THE DISCLOSURE Compounds having the formula: wherein R is hydrogen, mono- or dihalo, amino, nitro, cyano, hydroxy, trifluoromethyl, mercapto, lower alkyl, lower alkoxy, alkanoyl, lowercycloalkyl carboxy, alkoxycarbonyl, mono- or di-lower alkyl substituted amino, alkanoylamino, lower alkyl thio, loweralkylsulfonyl, sulfamoyl, lower alkyl substituted sulfumoyl, phenyl or phenyl substituted with halo, lower alkyl, lower alkoxy, trifluoromethyl, hydroxy, amino, cyano or nitro; X is SO2, SO, S or C=O; and A is an amine selected from the group: wherein R1 is hydrogen or R2CH2 wherein R2 is mono- or dilower-alkylamino, mono- or di-N-lower alkylaminolower-alkyl, (2-furyl)methylamino, benzylamino, lowercycloalkylamino, 1-pyrroli-dinyl, 1-piperidinyl, 1-hexahydroazepinyl, 1-octahydroazocinyl, 3-thiazolidinyl, 4-morpholinyl or 4-thiomorpholinyl; R3 is hydrogen or (1-piperidinyl)methyl with the proviso that when R3 is (1-piperidinyl)methyl, R1 is hydrogen; n is 1 to 4, and the pharmacologically acceptable salts thereof, have a selective action on H2 histamine receptors and which inhibit gastric acid secretion. |
| priorityDate | 1981-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.